Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EMN 2018 | Biomarkers of amyloidosis

New insights into amyloid light-chain (AL) amyloidosis have emerged in recent years. Here, Giampaolo Merlini, MD, from the University of Pavia, Paiva, Italy, gives an overview of the mechanisms behind this rare condition at the 1st European Myeloma Network Meeting (EMN), in Turin, Italy. Dr Merlini then discusses the importance of biomarkers in the reflection of pathogenic mechanisms of AL amyloidosis, highlighting key biomarkers, such as NT-proBNP and GDF-15.